Report overview
The global Gene Fragment market was valued at US$ 271.5 million in 2023 and is projected to reach US$ 560.4 million by 2030, at a CAGR of 10.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key players of gene fragment include Integrated DNA Technologies, Thermo Scientific, Eurofins Scientific, GenScript Biotech, Azenta Life Sciences, etc. The top five players hold a share over 70%. North America is the largest market, has a share about 40%, followed by Asia-Pacific, and Europe, with share 29% and 25%, separately.
Gene fragments are pieces of genes containing only the exons (those parts of the gene which actually encode the protein sequence). They are composed of cDNA. Gene Fragment can be used in CRISPR-Based Genome Editing, Recombinant Antibody Engineering, cloning process, qPCR and PCR Controls, Enzyme Engineering, Vaccine Research, High Resolution Melt (HRM) Assays etc field.
This report aims to provide a comprehensive presentation of the global market for Gene Fragment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Fragment. This report contains market size and forecasts of Gene Fragment in global, including the following market information:
Global Gene Fragment Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Gene Fragment Market Sales, 2019-2024, 2025-2030, (Million bp)
Global top five Gene Fragment companies in 2023 (%)
We surveyed the Gene Fragment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gene Fragment Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (Million bp)
Global Gene Fragment Market Segment Percentages, by Type, 2023 (%)
0-999 bp
1000-1999 bp
2000-3999 bp
4000+ bp
Global Gene Fragment Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (Million bp)
Global Gene Fragment Market Segment Percentages, by Application, 2023 (%)
CRISPR-based Genome Editing
Antibody Engineering
Cloning Process
Others
Global Gene Fragment Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (Million bp)
Global Gene Fragment Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gene Fragment revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Gene Fragment revenues share in global market, 2023 (%)
Key companies Gene Fragment sales in global market, 2019-2024 (Estimated), (Million bp)
Key companies Gene Fragment sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Integrated DNA Technologies
Thermo Scientific
Eurofins Scientific
GenScript Biotech
Azenta Life Sciences
Twist Bioscience
Synbio Technologies
Bio Basic
BiOligo Biotechnology
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gene Fragment, market overview.
Chapter 2: Global Gene Fragment market size in revenue and volume.
Chapter 3: Detailed analysis of Gene Fragment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gene Fragment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Gene Fragment capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
